Related Experiment Video
Updated: May 20, 2025

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
Volatile Compounds in Musk and Their Anti-Stroke Mechanisms
Chengli Zheng1, Xin Shi1, Qinling Yang2
1Sichuan Institute of Musk Deer Breeding, Sichuan Institute for Drug Control, Chengdu 611845, China.
Abstract:
Background/Objectives: Musk is a widely used traditional Chinese medicine derived from musk deer that has the pharmacological effects of "activating blood dredging collateral" and "consciousness-restoring resuscitation". Its volatile compounds (VCs) play a key role in these effects, especially in the treatment of stroke. However, there have been no comprehensive studies on the differences in the VCs of these different musks. This study investigated the differences in the VCs of different musks and the potential targets and mechanisms of action for stroke. Methods: Different musks were studied via GC-MS, and the potential targets and mechanisms of VCs associated with stroke were investigated using network pharmacology. Results: A total of 99 VCs were detected in 79 musk samples. The most important VCs of different colours and forms were muscone, phenol, acetic acid, and isovaleric acid. Further study revealed that the change in organic acids and ketones was the cause of the significant difference between white musk and other types of musk. In addition, network pharmacological analyses identified 180 potential targets of the major volatile compounds of musk associated with stroke, and five key targets (SRC, EGFR, ESR1, PTGS2, and DRD2). Enrichment analysis showed that these key targets play an important role in neural related pathways. The molecular docking results confirmed that the key targets can effectively bind with the main VCs (muscone and phenol). Conclusions: These findings provide valuable insights into the distinct volatile compositions of various types of musk and underscore the significant potential of volatile compounds (VCs) in stroke treatment.
More Related Videos
Related Concept Videos
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Cholinergic Antagonists: Pharmacokinetics
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...

